|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.75 USD | +2.07% |
|
+3.13% | +11.96% |
| 06-29 | Zai Lab Insider Sold Shares Worth $428,545, According to a Recent SEC Filing | MT |
| 06-16 | Zai Lab Receives EU Orphan Drug Designation for Lung Cancer Drug | MT |
Main competitors
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -.--% | -.--% | -8.92x | 4.16x | 3.96x | -7.31x | -6.86x | 2.22B | ||
| 0.59% | 0.67% | 17.16x | 1.98x | 3.76x | 10.09x | 11.16x | 67.44B | ||
| 0.59% | 0.61% | 26.81x | 4.03x | 5.52x | 16.19x | 20.47x | 53.98B | ||
| -.--% | -.--% | 33.81x | 6.78x | 11.45x | 21.68x | 25.47x | 41.77B | ||
| 3.32% | 3.4% | -46.24x | 2.52x | 3.25x | 9.6x | 11.2x | 41.15B | ||
| -.--% | -.--% | 30.53x | 1.58x | 3.49x | 11.03x | 12.81x | 29.58B | ||
| -.--% | -.--% | -8.52x | 5.17x | 12.36x | -7.59x | -7.17x | 29.28B | ||
| -.--% | -.--% | 17.02x | 3.41x | 3.26x | 9.87x | 9.69x | 23.43B | ||
| -.--% | 0.05% | 55.71x | 5.48x | 6.01x | 41.72x | 38.59x | 19.11B | ||
| -.--% | -.--% | 26.44x | 3.7x | 5.42x | 14.56x | 20.11x | 16.82B | ||
| -.--% | -.--% | -35.71x | -6.25x | 16.71x | -50.76x | -53.18x | 15.36B | ||
| -.--% | -.--% | -123.58x | 13006.89x | 12.7x | -112.62x | -125.41x | 12.64B | ||
| -.--% | -.--% | 16.96x | - | 3.61x | 13.22x | 15.85x | 11.55B | ||
| 0.16% | 0.17% | 57.36x | 23.39x | 34.76x | 49.16x | 50.7x | 11.12B | ||
| -.--% | -.--% | 48.69x | - | - | - | - | 11.07B | ||
| 2.84% | 3.28% | 11.84x | 1.03x | 1.8x | 7.28x | 9.75x | 6.19B | ||
| 1.6% | 1.77% | 14.11x | 1.3x | 2.47x | 6.4x | 7.76x | 5.65B | ||
| 0.38% | 0.45% | 27.05x | - | 7.24x | 19.2x | 22.93x | 5.5B | ||
| Average | 0.53% | 0.58% | 8.92x | 871.01x | 8.10x | 3.04x | 3.76x | 22.43B | |
| Weighted average by Cap. | 0.59% | 0.63% | 10.45x | 441.13x | 7.20x | 7.38x | 8.69x |
- Stock Market
- Stocks
- ZLAB Stock
- Sector Zai Lab Limited
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
















